Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world Perampanel Monotherapy in Children with Epilepsy
ChiCTR2200066392Phase 4Not yet recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Sep 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perampanel in epilepsy, sponsored by Guangzhou Women and Children's Medical Center. Primary endpoint: Efficacy evaluation. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2200066392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066392.